Moderna Stock News

Moderna stock toppled Friday after advisors to the CDC and Prevention ended the universal recommendation for Covid vaccines.

CAMBRIDGE, MA / ACCESS Newswire / September 19, 2025 / Moderna announced today that the first mRNA vaccines fully manufactured in Canada are being shipped to provinces and territories. This milestone advances Canada's domestic vaccine production capacity and strengthens national health security.

The reworked ACIP will make its debut Friday when the panelists weigh the suite of new Covid boosters from Pfizer, Moderna and Novavax.

Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in LP.8.1-neutralizing antibodies across age groups Clinical findings reinforce preclinical data supporting recent FDA approval of 2025-2026 formula of Spikevax CAMBRIDGE, MA / ACCESS Newswire / September 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced positive preliminary immunogenici...

On Friday, MRNA stock dropped 7% following a report from The Washington Post that stated a group of health officials reportedly used the Vaccine Adverse Event Reporting System to link the deaths of 25 children to COVID-19 vaccines. This drop brings the stock's year-to-date decline to almost 45%.

Pharma stocks took a fresh hit on Friday following a report in The Washington Post that the U.S. Food and Drug Administration reportedly plans to link COVID-19 vaccines with the deaths of 25 minors.

Shares of two entertainment giants pushed higher for a second straight day as investors weighed the possibility of a takeover bid, while vaccine makers came under pressure following a report that health officials from the Trump administration seek to link COVID-19 vaccines with child deaths.

Shares in Pfizer and Moderna fell 3.9% and 7.4%, respectively.